121 related articles for article (PubMed ID: 4666763)
1. A therapeutic evaluation to the pathogeneses of deep keratitis of obscure origin.
Hamed HH
Bull Ophthalmol Soc Egypt; 1972; 65(69):115-20. PubMed ID: 4666763
[No Abstract] [Full Text] [Related]
2. Anti-inflammatory effectiveness of topically administered corticosteroids in the cornea without epithelium.
Kupferman A; Leibowitz HM
Invest Ophthalmol; 1975 Mar; 14(3):252-5. PubMed ID: 1116925
[TBL] [Abstract][Full Text] [Related]
3. [Subscleral administration of hydrocortisone and prednisolone in certain keratites].
Opalev LM
Oftalmol Zh; 1973; 28(3):178-80. PubMed ID: 4720215
[No Abstract] [Full Text] [Related]
4. Topically administered corticosteroids and treatment of inflammatory keratitis.
Leibowitz HM; Kupferman A
Invest Ophthalmol; 1975 May; 14(5):337-40. PubMed ID: 1126821
[No Abstract] [Full Text] [Related]
5. Prolonged release medication in the treatment of eye disease.
Lerman S
Isr J Med Sci; 1972; 8(8):1402-5. PubMed ID: 4647794
[No Abstract] [Full Text] [Related]
6. Effect of concurrent topical corticosteroid and NSAID therapy of experimental keratitis.
Leibowitz HM; Ryan WJ; Kupferman A; DeSantis L
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1226-9. PubMed ID: 3733368
[TBL] [Abstract][Full Text] [Related]
7. [Corneal complications of cortisone therapy].
Myska V
Cesk Oftalmol; 1967 Jul; 23(4):264-71. PubMed ID: 6077835
[No Abstract] [Full Text] [Related]
8. Deep keratitis of obscure origin.
Hamed HH
Bull Ophthalmol Soc Egypt; 1968; 61(65):113-6. PubMed ID: 5744605
[No Abstract] [Full Text] [Related]
9. Management of suppurative keratitis.
Coster DJ
Trans Ophthalmol Soc N Z; 1982; 34():59-63. PubMed ID: 6953696
[No Abstract] [Full Text] [Related]
10. Management of inflammation in the cornea and conjunctiva.
Leibowitz HM
Ophthalmology; 1980 Aug; 87(8):753-8. PubMed ID: 7443202
[TBL] [Abstract][Full Text] [Related]
11. Avoiding eye damage from topical corticosteroids.
Drug Ther Bull; 1987 Apr; 25(8):29-30. PubMed ID: 3582180
[No Abstract] [Full Text] [Related]
12. Investigations on the activity of p-chlorophenylamide of 3-methyl-5-benzoylaminoisothiazole-4-carboxylic acid (ITCL) in the experimental keratitis.
Giełdanowski J
Arch Immunol Ther Exp (Warsz); 1983; 31(5):621-9. PubMed ID: 6326706
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of non-steroid topical anti-inflammatory agents.
Singh YP; Bharti S; Sagar R
Indian J Ophthalmol; 1983 Sep; 31(5):570-4. PubMed ID: 6368385
[No Abstract] [Full Text] [Related]
14. Diagnosis and management of dry eyes.
Wright P
Trans Ophthalmol Soc U K (1962); 1971; 91():119-28. PubMed ID: 5291517
[No Abstract] [Full Text] [Related]
15. [Local cortico-therapy in odonto-stomatology].
Bourgeois G
Chir Dent Fr; 1967 Nov; 37(43):47-52. PubMed ID: 5234994
[No Abstract] [Full Text] [Related]
16. A new ocular insert device for continuous constant-rate delivery of medication to the eye.
Dohlman CH; Pavan-Langston D; Rose J
Ann Ophthalmol; 1972 Oct; 4(10):823-32. PubMed ID: 4562270
[No Abstract] [Full Text] [Related]
17. Topical anti-inflammatory agents in an animal model of microbial keratitis.
Gritz DC; Lee TY; Kwitko S; McDonnell PJ
Arch Ophthalmol; 1990 Jul; 108(7):1001-5. PubMed ID: 2369336
[TBL] [Abstract][Full Text] [Related]
18. Treatment of deep viral keratitis.
Scuderi G; Recupero SM; Balestrazzi E
Ann Ophthalmol; 1981 Apr; 13(4):437-41. PubMed ID: 6166232
[No Abstract] [Full Text] [Related]
19. Prolonged release hydrocortisone therapy.
Lerman S; Davis P; Jackson WB
Can J Ophthalmol; 1973 Jan; 8(1):114-8. PubMed ID: 4705522
[No Abstract] [Full Text] [Related]
20. [Cogan-I syndrome: interstitial keratitis with sudden deafness].
Seel J; Meyer-Schwickerath G
Harefuah; 1973 Nov; 85(10):452-4. PubMed ID: 4544438
[No Abstract] [Full Text] [Related]
[Next] [New Search]
